Keytruda RCC Approval/I-O – Toni Choueiri, MD, and Robert Figlin, MD, discuss the recent Keytruda approval in renal cell carcinoma (RCC)

Keytruda RCC Approval/I-O – Toni Choueiri, MD, and Robert Figlin, MD, discuss the recent Keytruda approval in renal cell carcinoma (RCC)

Thursday May 16, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Toni Choueiri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, discuss Keytruda's approval in renal cell carcinoma (RCC).

Featured Videos

Parameswaran Hari, MD, discusses the role of CAR-T therapy in multiple myeloma

Saad Usmani, MD, FACP, considers data in smoldering MM coming out of ASCO 2019

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents